The weekly chart shows that LRS has been consolidating for several years between a range of 1-4c and has broken out at the end of 2020 with impressive volume. An up trend has been established since July 2020 and is continuous, it appears. The daily chart shows a text book cup and handle pattern which is bullish. Since the 19th January, LRS has broken out and returned to test support. This is a very bullish pattern and it does look like blue skies once the recent ATH has been taken out. Just bought a few so that I can monitor its progress with interest. Daily volume has also increased and has been mirrored by the weekly chart.(DYOR, not to be regarded as advice).
- Forums
- Charts
- LRS chart
The weekly chart shows that LRS has been consolidating for...
-
- There are more pages in this discussion • 5,810 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Add LRS (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $468.9M |
Open | High | Low | Value | Volume |
17.0¢ | 17.5¢ | 16.5¢ | $2.906M | 17.15M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 1806363 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 634221 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 1793844 | 0.165 |
36 | 1906519 | 0.160 |
29 | 1276857 | 0.155 |
59 | 3277135 | 0.150 |
19 | 1446868 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 624681 | 29 |
0.175 | 1944582 | 28 |
0.180 | 1633056 | 21 |
0.185 | 1189049 | 19 |
0.190 | 787124 | 17 |
Last trade - 11.40am 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
LRS (ASX) Chart |